文献速递神经肿瘤神经重症

右美托咪定清醒镇静与睡-醒-睡开颅术在胶质瘤手术中的比较:180例患者分析

Conscious sedation with dexmedetomidine compared with asleep-awake-asleep craniotomies in glioma surgery: an analysis of 180 patients.
PubMed 文献 · J Neurosurg · 2018-01-12

该研究回顾性分析了2009至2015年间180例胶质瘤清醒开颅手术,比较右美托咪定清醒镇静(n=75)与丙泊酚-瑞芬太尼睡-醒-睡(n=105)两种麻醉方式。清醒镇静组阿片类、血管活性及抗高血压药物用量显著更少(p<0.001),术后住院时间和手术时长也显著更低(p<0.001)。作者结论认为右美托咪定镇静适度并具抗焦虑作用,停药后可快速可靠地进行神经功能评估。

要点

  • 清醒镇静组(n=75)较睡-醒-睡组(n=105)显著减少阿片类、血管活性及抗高血压药物用量(p<0.001)。
  • 清醒镇静组术后住院时间和手术时长均显著低于睡-醒-睡组(p<0.001)。
  • 作者认为右美托咪定镇静适度、具抗焦虑作用,停药后便于快速可靠的神经功能评估。

核心结论

  • 使用右美托咪定可为清醒手术创造优良条件,其镇静适度并具抗焦虑作用,停药后可快速可靠地进行临床神经功能评估。
  • 作者认为这可能减少抗高血压药和血管活性药用量及住院时间,同时可能确保更快速的手术。

研究设计与样本

  • 回顾性分析2009至2015年间224例清醒手术中180例胶质瘤切除患者的资料。
  • 清醒镇静组(n=75)使用右美托咪定输注;睡-醒-睡组(n=105)使用丙泊酚-瑞芬太尼,置入喉罩并在评估期拔管。
  • 记录不良事件及所用药物的剂量和使用频率。

主要发现

  • 清醒镇静组(n=75)较睡-醒-睡组(n=105)阿片类药物用量显著更少(p<0.001)。
  • 清醒镇静组较睡-醒-睡组血管活性药物用量显著更少(p<0.001)。
  • 清醒镇静组较睡-醒-睡组抗高血压药物用量显著更少(p<0.001)。
  • 清醒镇静组术后住院时间显著低于睡-醒-睡组(p<0.001)。
  • 清醒镇静组手术时长显著低于睡-醒-睡组(p<0.001)。

临床怎么用

  • 原文结论指出右美托咪定可为清醒手术创造优良条件,镇静适度并具抗焦虑作用,停药后便于快速可靠的神经功能评估。
  • 作者认为使用右美托咪定可能减少抗高血压药和血管活性药用量及住院时间,同时可能确保更快速的手术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVEAwake craniotomies have become a feasible tool over time to treat brain tumors located in eloquent regions. Different techniques have been applied in neurooncology centers. Both "asleep-awake-asleep" (asleep) and "conscious sedation" were used subsequently at the authors' neurosurgical department. Since 2013, the authors have only performed conscious sedation surgeries, predominantly using the α2-receptor agonist dexmedetomidine as the anesthetic drug. The aim of this study was to compare both mentioned techniques and evaluate the clinical use of dexmedetomidine in the setting of awake craniotomies for glioma surgery.METHODSThe authors retrospectively analyzed patients who underwent operations either under the asleep condition using propofol-remifentanil or under conscious sedation conditions using dexmedetomidine infusions. In the asleep group patients were intubated with a laryngeal mask and extubated for the assessment period. Adverse events, as well as applied drugs with doses and frequency of usage, were recorded.RESULTSFrom 224 awake surgeries between 2009 and 2015, 180 were performed for the resection of gliomas and included in the study. In the conscious sedation group (n = 75) significantly fewer opiates (p < 0.001) and vasoactive (p < 0.001) and antihypertensive (p < 0.001) drugs were used in comparison with the asleep group (n = 105). Furthermore, the postoperative length of stay (p < 0.001) and the surgical duration (p < 0.001) were significantly lower in the conscious sedation group.CONCLUSIONSUse of dexmedetomidine creates excellent conditions for awake surgeries. It sedates moderately and acts as an anxiolytic. Thus, after ceasing infusion it enables quick and reliable clinical neurological assessment of patients. This might lead to reducing the amount of administered antihypertensive and vasoactive drugs as well as the length of hospitalization, while likely ensuring more rapid surgery.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Suero Molina E, Schipmann S, Mueller I, et al. Conscious sedation with dexmedetomidine compared with asleep-awake-asleep craniotomies in glioma surgery: an analysis of 180 patients. J Neurosurg. 2018. PMID: 29328000. doi:10.3171/2017.7.JNS171312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。